This site uses cookies to ensure the best viewing experience for our readers. Read more about it Got it

CTech's Monday Roundup of Israeli Tech News

An entrepreneur is like a professional basketball player, says serial entrepreneur Shlomo Kramer; S&P reaffirms Israel’s AA- credit rating with a stable outlook

CTech 16:1405.08.19

Interview | An entrepreneur is like a professional basketball player, says serial entrepreneur Shlomo Kramer. Kramer, who previously co-founded firewall pioneer Check Point, cybersecurity company Imperva, and anti-fraud company Trusteer, is the co-founder and CEO of Tel Aviv-based cybersecurity company Cato Networks. Read more

 

S&P reaffirms Israel’s AA- credit rating with a stable outlook. The credit agency said Israel’s economy is “diversified, competitive, and resilient,” and that the country’s main credit limiters are geo-political risks and government debt. Read more
Tel Aviv. Photo: Shutterstock Tel Aviv. Photo: Shutterstock
Israel Innovation Authority to set up computational biology innovation lab. A joint venture with the National Digital Israel Initiative, the new venture aims to leverage existing Israeli knowledge and talent into a local computational biology industry. Read more

 

World’s largest beer company AB InBev to scout for Israeli startups. Headquartered in Leuven, Belgium, AB InBev owns around 500 brands, including Beck’s, Budweiser, Corona, and Stella Artois. Read more

 

Israel’s Defense Ministry demonstrates new autonomous armored vehicles. Dubbed Carmel, the new vehicles are intended to replace the Merkava tank, Israel’s main battle tank for the past three decades. The lightweight, self-driving vehicles come equipped with artillery capabilities. Read more

 

To resume growing medical cannabis, Tikun Olam founder must give up control. Until recently, Tikun Olam controlled half the Israeli medical cannabis market, but new regulations left it behind. Read more

 

Cannabis pharmaceutical outfit Nextage wants to raise $15 million in Canada. The company, which is currently in the process of merging with Tel Aviv-listed Micromedic Technologies, intends to use the funding to build a manufacturing facility for its products in Israel and to continue developing its pipeline. Read more

 

Can-Fite BioPharma signs South Korean distribution agreement for psoriasis treatment drug. The agreement, signed with pharma company Kyongbo Pharm, is contingent upon regulatory approval for the drug, currently in phase 3 clinical trials. Read more
Cancel Send
    To all comments